Intralesional Meglumine Antimoniate for Treatment of Cutaneous Leishmaniasis Patients with Contraindication to Systemic Therapy from Rio de Janeiro (2000 to 2006)

We evaluated the effectiveness and safety of intralesional meglumine antimoniate (MA) in 24 not submitted to previous treatment patients with cutaneous leishmaniasis (CL) and with contraindication to systemic therapy. Each treatment consisted of one to four intralesional applications of MA at 15-day...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Vasconcellos, Érica de Camargo Ferreira e, Pimentel, Maria Inês Fernandes, Schubach, Armando de Oliveira, de Oliveira, Raquel de Vasconcellos Carvalhaes, Azeredo-Coutinho, Rilza Beatriz, Silva, Fátima da Conceição, Salgueiro, Mariza de Matos, Moreira, João Soares, Madeira, Maria de Fátima, Baptista, Cibele, Valete-Rosalino, Cláudia Maria
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The American Society of Tropical Medicine and Hygiene 2012
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3414560/
https://ncbi.nlm.nih.gov/pubmed/22855754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.2012.11-0612
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg